Medigate is a technology company.
Medigate has raised $25.0M across 1 funding round.
Medigate has raised $25.0M in total across 1 funding round.
Medigate is a cybersecurity platform specializing in protecting healthcare environments by securing Internet of Medical Things (IoMT), IoT, operational technology (OT), and IT devices. It provides comprehensive asset visibility, risk management, threat detection, and compliance tools through a modular, SaaS-based solution deployed in thousands of hospitals worldwide, safeguarding over 10 million IoT devices and 7 million IoMT devices.[1][3][4] Acquired by Claroty in January 2022, Medigate now operates as Medigate by Claroty, earning recognition as the Best in KLAS for Healthcare IoT Security for four consecutive years and serving over 2,000 hospitals and clinics.[3][5][8] It solves the growing cybersecurity risks from connected medical devices, IT/OT convergence, and cyber-physical systems blind spots, enabling healthcare delivery organizations (HDOs) to maintain operational efficiency, patient safety, and regulatory compliance like HIPAA and NIST.[5][6][7]
Medigate pioneered healthcare IoT security as the first company to recognize and address the critical vulnerabilities in connected medical devices.[8] Founded around 2017 (aligned with similar sector entrants), it quickly gained traction with its purpose-built platform, deploying solutions across thousands of global hospitals and earning dozens of accolades.[2][4][5] A pivotal moment came in January 2022 when Claroty, a leader in cyber-physical systems security, acquired Medigate, combining its healthcare IoMT expertise with Claroty's industrial OT strengths to create a unified Extended IoT (XIoT) powerhouse.[3][4][8] This integration enhanced scalability and positioned it as a comprehensive solution for hospitals, clinics, and labs.[3]
Medigate rides the surge in digital transformation and IT/OT convergence in healthcare, where cyber-physical systems like unmanaged DICOM workstations expose patient data to ransomware, as seen in the 2023 Harvard Pilgrim attack affecting 2.6 million records.[6] Timing is critical amid rising threats to sensitive patient information and regulatory pressures (e.g., HHS 405(d), HIPAA updates, California's zero-trust mandates), making device visibility and segmentation non-negotiable.[5][6] Market forces favoring Medigate include explosive IoMT growth, XIoT expansion, and demand for clinically-aware security that minimizes downtime without disrupting care.[3][4][7] It influences the ecosystem by setting benchmarks for HDO cyber resilience, integrating with partners like Elisity for microsegmentation, and driving 85% visibility improvements that enable zero-trust practices across sectors.[6][7]
Medigate by Claroty is poised for expansion as healthcare cybersecurity demands intensify in 2025, with integrations like microsegmentation becoming table stakes for compliance and defense against evolving ransomware.[6] Trends like AI-driven threat intelligence, deeper XIoT coverage, and global regulatory harmonization will amplify its role, potentially extending beyond hospitals to labs and telehealth. Its track record positions it to influence standards, much like its KLAS dominance, ensuring HDOs deliver secure connected care amid escalating risks—solidifying its place as the go-to for protecting the lifeblood of modern medicine.[5][6]
Medigate has raised $25.0M in total across 1 funding round.
Medigate's investors include Blackbird Ventures Australia, Bond, CITG Capital, E1 Ventures, Footwork, FPV Fund, Heartcore Capital, InterWest, Jigsaw VC, Partech Ventures, Sapphire Ventures, Shasta Ventures.
Medigate has raised $25.0M across 1 funding round. Most recently, it raised $25.0M Series B in August 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2020 | $25.0M Series B | Blackbird Ventures Australia, Bond, CITG Capital, E1 Ventures, Footwork, FPV Fund, Heartcore Capital, InterWest, Jigsaw VC, Partech Ventures, Sapphire Ventures, Shasta Ventures, Square Peg Capital, YOBE Ventures, Zetta Venture Partners, Aayush Phumbhra, Bill Tai, Kenneth Goldman, Konstantin Othmer, Madhu Chamarty, Sahin Boydas, Trevor Folsom |